Prevalence of Cancer and Popularity of Companion Diagnostics Will Stimulate the Global Cancer Biomarkers Market by 2019: TechNavio
London, 12 January 2015 –Increased prevalence of cancer has resulted in the unprecedented growth of the Global Cancer Biomarkers Market, which is expected to post a CAGR of 18.26 percent from 2014-2019, says research firm TechNavio. The number of cancer-related death is growing globally, topping 8 million in 2012. Lifestyle factors like a poor…
